MaxCyte, Inc. (NASDAQ:MXCT) Q2 2024 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Welcome to MaxCyte Second Quarter Earnings Conference Call.
Maxcyte Inc. (MXCT)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Cadian Capital Eric Bannasch | 7,622,941 | $29,881,929 | +17% | 1.48% |
| 2. | Millennium Management Israel Englander | 5,177,953 | $20,297,576 | -17% | 0% |
| 3. | Portolan Capital Management George Mccabe | 1,687,650 | $6,615,588 | -2% | 0.54% |
| 4. | Marshall Wace LLP Paul Marshall And Ian Wace | 499,669 | $1,958,702 | 0% | |
| 5. | Roubaix Capital Christopher Hillary | 414,818 | $1,626,087 | -17% | 1.02% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.90 | 70,443 | 100,000 | 2024-06-10 | Filing | ||
| $4.87 | 29,557 | 29,557 | 2024-06-07 | Filing | ||
| $4.32 | 80,000 | Director | 100,000 | 2023-03-29 | Filing | |
| $11.12 | 20,000 | Director | 20,000 | 2021-11-22 | Filing | |
| $13.00 | 1,800,000 | Large Shareholder | 13,971,334 | 2021-07-30 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.36 | 17,857 | 25,000 | 2024-08-02 | Filing | ||
| $4.54 | 15,476 | 25,000 | 2024-08-01 | Filing | ||
| $4.75 | 3,000 | 141,950 | 2024-07-26 | Filing | ||
| $4.03 | 13,531 | 25,000 | 2024-07-09 | Filing | ||
| $4.03 | 19,802 | 25,000 | 2024-07-08 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 7,341,386 | $34,504,514 | 0% | |
| 2. | 5,282,108 | $24,825,907 | 0% | |
| 3. | 5,043,356 | $23,703,773 | 6.02% | |
| 4. | 3,481,010 | $16,360,746 | 0% | |
| 5. | 2,833,715 | $13,318,460 | 0% |
News See All
MaxCyte, Inc. (NASDAQ:MXCT) Q1 2024 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the MaxCyte First Quarter 2024 Earnings Conference Call. At this time all participants are in a listen-only mode.
MaxCyte, Inc. (NASDAQ:MXCT) Q4 2023 Earnings Call Transcript
MaxCyte, Inc. beats earnings expectations. Reported EPS is $-0.05, expectations were $-0.1. MaxCyte, Inc.
Hedge Funds Say These Penny Stocks Are Poised to Explode
Despite common belief, not all penny stocks are inherently risky and suitable only for short-term gains.
MaxCyte, Inc. (NASDAQ:MXCT) Q3 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by, and welcome to MaxCyte’s Third Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode.
MaxCyte, Inc. (NASDAQ:MXCT) Q2 2023 Earnings Call Transcript
Operator: Thank you for standing by, and welcome to MaxCyte's Second Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode.
MaxCyte, Inc. (NASDAQ:MXCT) Q1 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by and welcome to MaxCyte’s First Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode.
MaxCyte, Inc. (NASDAQ:MXCT) Q4 2022 Earnings Call Transcript
Operator: Good day and thank you for standing by and welcome to MaxCyte's Fourth Quarter Earnings Conference Call. Please be advised that today's conference is being recorded.
Top 5 Stock Picks of Eli Casdin's Casdin Capital
In this article, we discuss the top 5 stock picks of Eli Casdin's Casdin Capital.
Should You Invest in MaxCyte (MXCT)?
Investment management company RGA Investment Advisors recently released its third-quarter 2022 investor letter. A copy of the same can be downloaded here.
Billionaire Hedge Funds
